delayed wound healing, corneal perforations, optic nerve damage, defects in visual acuity and fields of vision, allergic reactions, dysgeusia, eye pain, foreign body sensation, headache, others.
Global pharma major Lupin Limited on Monday announced that it has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results